The new report by Expert Market Research titled, ‘Global Antiplatelet Drug Market Share, Report and Forecast 2023-2028’, gives in-depth analysis of the global antiplatelet drug market, assessing the market based on its segments like drug, drug class, applications, different routes of administration, distribution channel, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents –https://www.expertmarketresearch.com/reports/antiplatelet-drugs-market/requestsample
The key highlights of the report include:
Market Overview (2018-2028): –
- Forecast CAGR (2023-2028): 7%
Due to the rising organic and inorganic growth taking place within the industry, the antiplatelet drug market is expected to step forward during the forecast period. In addition, the generic market is also growing, thereby giving generic antiplatelet drug manufacturers a boost. It is also anticipated that the amount of money that businesses invest on research and development will contribute to the antiplatelet drug market’s sales in the future.
Industry Definition and Major Segments
Antiplatelet medications are mistakenly referred to as drugs for blood thinning. They do not thin the blood but interfere with the essential process of blood clotting instead. The clumping of blood cells is typically decreased by the antiplatelet agent, thereby reducing the potentially dangerous blood clots. People who are at high risk for heart failure will avoid the risk of strokes and heart attacks when given antiplatelet agents.\
Read Full Report with Table of Contents –https://www.expertmarketresearch.com/reports/antiplatelet-drugs-market
By drug, the market is divided into:
- Aspirin
- Clopidogrel
- Ticagrelor
- Prasugrel
- Dipyridamole
- Ticlopidine
- Abciximab
- Tirofiban
- Others
On the basis of drug class, the industry can be segmented into:
- Platelet Aggregation Inhibitors
- Glycoprotein Platelet Inhibitors
- Protease-Activated Receptor-1 Antagonists
- Others
Based on applications, the industry can be categorised into:
- Myocardial Infraction
- Percutaneous Coronary Interventions
- Angioplasty
- Arterial Thrombosis
- Dental Surgeries
- Others
The different routes of administration of antiplatelet drugs are:
- Oral
- Injectable
The various distribution channels of the product are:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Based on region, the market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Trends
Industry development is primarily due to evolving lifestyles, and an ageing population is contributing to a growing worldwide prevalence of heart diseases. Globally, some 15 million people a year suffer from heart strokes, according to the WHO. The big downside that hampers market growth is the rising risk of bleeding in highly complicated surgeries. The misconception of antiplatelet pharmaceutical products with blood-thinning drugs is also a major impediment to market development. The consumption of antiplatelet drugs in recent years has also been affected by side effects such as nausea, upset stomach, stomach pain, diarrhoea, rash, and itching.
With the number of players initiating clinical trials for antiplatelet drugs, North America is the dominating region. In addition, to develop new product alternatives, many academic universities are receiving research grants. Kengreal, an intravenous antiplatelet medication developed by The Medicines Company, for example, has received FDA approval. As Asia Pacific is an economically developing country, the forecast period is expected to spearhead it.
Key Market Players
The major players in the market are Glenmark Pharmaceuticals Ltd., Sanofi SA, Pfizer Inc., Baxter International Inc., Bayer AG, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Read More Reports:
Aprotic Solvents Market: https://www.marketwatch.com/press-release/aprotic-solvents-market-size-share-report-growth-analysis-price-trends-outlook-key-players-and-forecast-period-2023-2028-2022-12-19?mod=search_headline
Sex Reassignment Surgery Market: https://www.marketwatch.com/press-release/sex-reassignment-surgery-market-size-share-report-growth-analysis-price-trends-and-key-players-and-forecast-period-2021-2026-2022-12-26?mod=search_headline
About Us:
Expert Market Research (EMR) is a leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium-scale enterprises.
EMR customises syndicated reports according to client’s requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate, and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Media Contact
Company Name: Claight Corporation
Contact Person:-Ian Bell, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
